Sysmex is trying to shift from selling machines to building a steadier, higher‑profit stream from the testing supplies labs use every day, helped by new approvals, partnerships, and a wider sales push outside China. The upside is a broader global footprint and better margins, but policy pressure in China and the risk that costly expansion plans don’t pay off could still derail the story.Read more
Sysmex sells lab testing systems and the supplies that go with them, and the big bet is that an aging world and rising healthcare testing keep demand steadily climbing. If its push into new regions and a broader set of tests leads to more repeat supply sales, profits could improve—but pressure on testing prices in China could hold the story back.Read more
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
